|
|
|
COMPANY |
| |
Founded in 1997
to develop, test and
commercialize its
exclusive technology
benefiting from
technology barriers and
cost advantages that
competitors cannot match |
|
|
| |
The company is based in France with laboratoties on the
Genopole campus, near Evry, with
a subsidiary in Virginia, USA.
Currently it employs 12 people,
of which 10 are involved in R&D.
Biométhodes takes advantages of four key patent
families, two pertaining to
delignification and
decrystallization of cellulose
for which it has an exclusive
and worldwide license for the
pretreatment process invented by
Prof. Zhang at Virginia Tech
University and two pertaining to
its own enzyme optimisation
platform which is recognized as
of today as the most effective
solution for an optimal
transformation of cellulosic
material into many high value
products in addition to biofuel. |
|
| |
 |
|
| |
While collaborating with agricultural
producers, biofuels manufacturers and
chemical companies, Biométhodes’ goal is
to become a major technological player
by selling a commercially viable and
efficient technology that should form a
pillar of the « new green economy »
valued at over E50 billion by the
International Energy Agency by:
-
Minimizing the production cost of
biofuels and renewable chemicals so
as to successfully replace fossil
fuels and petrochemicals by
renewable alternatives derived from
agricultural and forest residues
-
Optimizing the value from biomass
and capital investments
|
|
|
|
|
|
